DrR Anderson

CLIN PROF

MD-MEDICINE

GRANTS

  • GRANT
    Primary Unloading and Delayed Reperfusion in ST-Elevation Myocardial Infarction: The STEMI DTU Trial
    Abiomed26 Mar 2024 - 26 Mar 2029
    Active
  • GRANT
    Phase I/II Clinical Trial of Human Allogeneic Cultureexpanded Bone marrow-derived Mesenchymal Stem Cells (hMSCs) in Patients with Ischemic Heart Failure with reduced ejection fraction (HFrEF) (CardiALLO NK1R+ MSC Trial)8
    Biocardia27 Jul 2023 - 26 Jul 2028
    Active
  • GRANT
    Impella-Supported PCI in High-Risk Patients with Complex Coronary Artery Disease and Reduced Left Ventricular Function: The PROTECT IV Trial
    Abiomed19 Jul 2022 - 18 Jul 2027
    Active
  • GRANT
    SMall Annuli Randomized To Evolut or SAPIEN Trial
    Medtronic Inc6 Jul 2021 - 5 Jul 2027
    Active
  • GRANT
    Effect of Intensive Medical Treatment on Quantified Coronary Artery Plaque Components with Serial Coronary CTA in Women with Non-Obstructive CAD
    National Institute of Health Nhlbi30 Jun 2021 - 31 Aug 2025
    Expired
  • GRANT
    A Double-Blind, Randomized, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of CLBS16 Delivery in Subjects with Coronary Microvascular Dysfunction and Without Obstructive Coronary Artery Disease
    Caladrius Biosciences26 Feb 2021 - 27 Jul 2023
    Closed
  • GRANT
    Randomized Controlled Pivotal Trial of Autologous Bone Marrow Mononuclear Cells Using the CardiAMP Cell Therapy system in Patients with refractory chronic myocardial ischemia
    Biocardia18 Dec 2020 - 17 Dec 2026
    Active
  • GRANT
    A Phase 1/2 Trial of Direct Administration of AdVEGF-All6A+, a Replication Deficient Adenovirus Vector Expressing a cDNA/Genomic Hybrid of Human Vascular Endothelial Growth Factor, to the Ischemic Myocardium of Subjects with Angina Pectoris Secondary to Coronary Artery Disease that is Refractory to Drug Therapy and Unsuitable for Revascularization
    Xylocor Therapeutics6 Jan 2020 - 14 Dec 2023
    Closed
  • GRANT
    A Pivotal, Multicenter, Blinded, Sham Procedure-Controlled Trial of Renal Denervation by the Peregrine System™ Kit, in Subjects with Hypertension
    Ablative Solutions12 Nov 2019 - 3 Nov 2024
    Closed
  • GRANT
    Women’s Ischemia Syndrome Evaluation (WISE) – Mechanisms of Coronary Microvascular Dysfunction Leading to Pre-Heart Failure with Preserved Ejection Fraction (HFpEF)
    National Institute of Health Nhlbi1 May 2019 - 28 Feb 2026
    Expired
  • GRANT
    A Phase I, Open-label Study of the Effects of Percutaneous Administration of an Extracellular Matrix Hydrogel, VentriGel, Following Myocardial Infarction
    Ventrix Inc6 Apr 2017 - 2 Sep 2023
    Closed
  • GRANT
    Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-term Effectiveness (ADAPTABLE)
    Patient-Centered Outcomes Research Institute22 Sep 2016 - 15 Jun 2021
    Expired
  • GRANT
    Randomized Controlled Pivotal Trial of Autologous Bone Marrow Mononuclear Cells Using the CardiAMP System in Patients with Post Myocardial Infarction Heart Failure (CardiAMP Heart Failure Trial)
    Biocardia9 Sep 2016 - 15 May 2027
    Active
  • GRANT
    A Randomized Evaluation oF the TriGuard™ HDH Embolic Deflection Device to Reduce the Impact of Cerebral Embolic LEsions after TransCatheter Aortic Valve ImplanTation
    *keystone Heart8 Jul 2016 - 3 Apr 2017
    Closed
  • GRANT
    Affordability and Real-world Antiplatelet Treatment Effectiveness After Myocardial Infarction Study
    Astrazeneca23 Nov 2015 - 13 Oct 2018
    Expired
  • GRANT
    AFFORDABILITY AND REAL-WORLD ANTIPLATELET TREATMENT EFFECTIVENESS AFTER MYOCARDIAL INFARCTION STUDY
    Astrazeneca14 Oct 2015 - 11 Oct 2022
    Closed
  • GRANT
    SALUS – The Direct Flow Medical Transcatheter Aortic Valve Replacement System Pivotal Trial The Safety and Effectiveness of the Direct Flow Medical Transcatheter Aortic Valve System
    Direct Flow Medical Inc30 Sep 2015 - 31 Jul 2023
    Closed
  • GRANT
    PHASE 2 PROSPECTIVE RANDOMIZED DOUBLE BLIND SHAM CONTROLLED PARALLEL GROUP MULTI CENTER TRIAL OF AMI MULTISTEM IN ......
    ABT Holding Company18 Mar 2015 - 29 Nov 2022
    Closed
  • GRANT
    A Registry to Assess the Ongoing Safety for Subjects that have been Randomized and Completed a Juventas Sponsored Heart Failure Protocol under IND # 14203
    Juventas Therapeutics18 Sep 2014 - 18 May 2017
    Expired
  • GRANT
    A Multicenter, Randomized,Double-blind,Placebo-controlled, Parallel Group Study to Evaluate the Efficacy, Safety, and Tolerability of Transendocardial Injection of Ixmyelocel-T in Subjects with Heart Failure due to Ischemic Dilated Cardiomyopathy
    Aastrom Biosciences27 Aug 2014 - 12 Oct 2022
    Closed
  • GRANT
    ALLSTAR (ALLOGENEIC HEART STEM CELLS TO ACHIEVE MYOCARDIAL REGENERATION)
    Capricor, Inc9 Apr 2014 - 10 Oct 2023
    Closed
  • GRANT
    A Phase I/II Study to Evaluate the Safety and Efficacy of JVS-100 Administered by Retrograde Delivery to Cohorts of Adults with Ischemic Heart Failure
    Juventas Therapeutics28 Feb 2014 - 4 Nov 2016
    Expired
  • GRANT
    ANDERSON PAYROLL OPERATING ACCOUNT
    University of Florida31 Oct 2013 - 7 Mar 2028
    Active
  • GRANT
    Renal Denervation in Patients with Uncontrolled Hypertension SYMPLICITY HTN-3
    Medtronic Vascular8 Jan 2013 - 22 Apr 2017
    Expired
  • GRANT
    RENAL DENERVATION IN PATIENTS WITH UNCONTROLLED HYPERTINSION- SYMPLICITY HTN-3
    Medtronic Vascular23 Apr 2012 - 31 Jan 2018
    Closed